Pharmaceutical giant AstraZeneca has covered the rooftop of an office building at its Maccles-field site with solar panels as part of multi-million pound investment in its Cheshire operations.
In August, AstraZeneca announced that it would invest in technical improvements at the £150 million facility, which employs around 1,800 people and produces cancer drugs such as Zoladex, one of the company’s biggest-selling products.
The improvements include 658 PV panels on one rooftop, which generates 230kW of electricity at peak. All of the electricity generated will be used on-site, which will reduce the facility’s annual carbon emissions by 82 tonnes.
Employees will be able to see the amount of energy being generated on display screens.
The installation is part of wider work on carbon, water and waste reduction at the Macclesfield cam-pus.
AstraZeneca is one of several major companies to sign up to the Science Based Targets initiative, which sets environmental targets in line with what science says is necessary to tackle global climate change.
A useful online guide to on-site energy generation is available here.